8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2013 / Comparative crossover trial
Ten healthy volunteers underwent BOLD-MRI before and 2 hours after consuming 1 g/kg dark chocolate (70% cocoa), with eight repeating the protocol with 1 g/kg white chocolate after at least 1 week. Mean medullary R2* was significantly lower after dark chocolate compared to baseline (28.2 ± 1.3 s-1 vs. 29.6 ± 1.3 s-1, p = 0.04), indicating increased oxygenation, while white chocolate caused no cortical or medullary changes. The change in medullary R2* correlated with circulating (epi)catechines (r = 0.74, p = 0.037) and was independent of plasma renin activity.
Pruijm M, Hofmann L, Charollais-Thoenig J, et al. Clin Nephrol, 2013. PMID 23557792
2013 / Two experimental trials (acute and chronic interventions)
Two experiments tested whether chewing gum before eating reduces motivation to eat, hunger, and energy intake acutely or chronically across two of three weeks. In Experiment 1, gum chewing did not affect the reinforcing value of food, but mint gum reduced liking of and energy intake from fruit; hunger was reduced immediately after chewing and after eating compared to no gum. In Experiment 2, gum chewing had no significant effect on total energy intake, but participants ate fewer meals, consumed more energy per meal, and had a lower nutrient adequacy ratio during gum-chewing weeks.
Swoboda C, Temple JL Eat Behav, 2013. PMID 23557811
2013 / Human challenge and cohort studies combined with animal intervention trials
Researchers investigated intestinal microbiota metabolism of dietary L-carnitine into trimethylamine-N-oxide (TMAO) in humans and mice. Following L-carnitine ingestion, omnivorous human subjects produced more TMAO than vegans or vegetarians through a microbiota-dependent mechanism. In 2,595 subjects undergoing cardiac evaluation, plasma L-carnitine predicted increased risks for prevalent cardiovascular disease and incident major adverse cardiac events, but only with concurrently high TMAO levels. In mice, chronic dietary L-carnitine supplementation altered cecal microbial composition, enhanced TMA and TMAO synthesis, and increased atherosclerosis, which did not occur when intestinal microbiota was concurrently suppressed.
Koeth RA, Wang Z, Levison BS, et al. Nat Med, 2013. PMID 23563705
2013 / Randomized crossover trial
In a randomized crossover study of 16 healthy young adults, researchers compared the effects of an evening meal of Swedish brown beans versus white wheat bread on markers measured at a standardized breakfast 11 to 14 hours later. Compared with white bread, the brown bean evening meal lowered post-breakfast blood glucose (-15%, p<0.01) and insulin (-16%, p<0.05) responses, increased PYY (51%, p<0.001), reduced ghrelin (-14%, p<0.05) and hunger sensations (-15%, p=0.05), increased GLP-2 (8.4%, p<0.05), and decreased IL-6 (-35%, p<0.05) and IL-18 (-8.3%, p<0.05). Breath hydrogen (141%, p<0.01), propionate (16%, p<0.05), and isobutyrate (18%, p<0.001) were also significantly higher following the brown bean meal.
Nilsson A, Johansson E, Ekström L, et al. PLoS One, 2013. PMID 23577078
2013 / Randomized crossover trial
In a randomized crossover study, 19 young adults consumed either boiled barley kernels (BK) or white wheat bread (WWB) as late evening meals, followed by standardized breakfast and lunch meals (10.5-16 h). Compared with WWB, the BK evening meal increased plasma GLP-1 at fasting (P < 0.05) and during the experimental day (P < 0.01), decreased fasting serum FFA (P < 0.05), and tended to reduce fasting serum IL-6 (P = 0.06). At lunch, voluntary energy intake decreased (P < 0.05) following BK. Furthermore, BK decreased incremental blood glucose area (P < 0.01), promoted higher breath H2 (P < 0.001), maintained adiponectin (P < 0.05), and reduced perceived hunger (P < 0.05) across 10.5-16 hours.
Johansson EV, Nilsson AC, Östman EM, et al. Nutr J, 2013. PMID 23577719
2013 / Randomized controlled trial
In a randomized trial, 161 patients with chronic anal fissures received either an 8-week true-elimination diet or a sham-elimination diet alongside topical medication. Complete fissure healing occurred in 69% of the true-diet group compared to 45% of controls (P < 0.0002). Among 60 healed patients undergoing subsequent double-blind challenges, fissures recurred in 13 patients tested with cow's milk protein and in 7 patients tested with wheat.
Carroccio A, Mansueto P, Morfino G, et al. Am J Gastroenterol, 2013. PMID 23588240
2013 / Sequential dietary intervention trial
Twenty healthy volunteers followed a 3-day usual diet, a 7-day high-salt diet (>=15 g NaCl/day), and a 7-day low-salt diet (<=5 g NaCl/day). Switching to a high-salt diet led to CD14++ monocyte activation, rapid expansion of the CD14++CD16+ subset and monocyte-platelet aggregates (MPAs), and a reciprocal decrease in CD14++CD16- and CD14+CD16++ subsets. High-salt intake was also associated with progressive hypoxia in the renal medulla and increased urinary MCP-1 excretion; these changes were completely reversed by a low-salt diet, while blood pressure remained unchanged.
Zhou X, Zhang L, Ji WJ, et al. PLoS One, 2013. PMID 23593194
2013 / Pilot intervention study
A pilot study evaluated 18 patients with mild-to-moderate Crohn's disease receiving escalating doses of oral vitamin D3 (from 1,000 IU/d up to 5,000 IU/d) for 24 weeks to reach serum levels above 40 ng/ml. Fourteen of the 18 patients required the maximal dose of 5,000 IU/d. Supplementation significantly increased serum 25(OH)D3 levels from 16±10 ng/ml to 45±19 ng/ml (P<0.0001) and reduced unadjusted mean CDAI scores by 112±81 points from 230±74 to 118±66 (P<0.0001). Quality-of-life scores also significantly improved (P=0.0004), while no significant changes in cytokines or other laboratory measures were observed.
Yang L, Weaver V, Smith JP, et al. Clin Transl Gastroenterol, 2013. PMID 23594800
2013 / Isotope-tracer metabolic study
Eight male participants ingested 500 mg of 13C-labeled cyanidin-3-glucoside, and biological samples were analyzed over 48 hours. Total 13C recovered in urine, breath, and feces was 43.9 ± 25.9% (range: 15.1-99.3%), with a relative bioavailability of 12.38 ± 1.38% (5.37 ± 0.67% in urine and 6.91 ± 1.59% in breath). Serum 13C-labeled metabolites peaked at 10.25 ± 4.14 h (maximum concentration: 5.97 ± 2.14 μmol/L), with half-lives ranging from 12.44 ± 4.22 to 51.62 ± 22.55 h. Metabolites included degradation products, phenolic, hippuric, phenylacetic, and phenylpropenoic acids.
Czank C, Cassidy A, Zhang Q, et al. Am J Clin Nutr, 2013. PMID 23604435
2013 / Intervention challenge study and prospective cohort study
In healthy participants, researchers evaluated TMAO production after a phosphatidylcholine challenge (ingestion of two hard-boiled eggs and d9-labeled phosphatidylcholine) before and after suppression of gut microbiota with oral broad-spectrum antibiotics. They also examined fasting plasma TMAO and major adverse cardiovascular events over 3 years in 4,007 patients undergoing elective coronary angiography. Plasma TMAO levels rose after the challenge, were markedly suppressed after antibiotics, and reappeared after antibiotic withdrawal. In the clinical cohort, increased plasma TMAO levels were associated with higher risk of major adverse cardiovascular events (hazard ratio for highest vs. lowest quartile, 2.54; 95% CI, 1.96 to 3.28; P<0.001), remaining significant after adjustment for traditional risk factors.
Tang WH, Wang Z, Levison BS, et al. N Engl J Med, 2013. PMID 23614584
2013 / Randomized crossover trial
Twenty moderately overweight women consumed high-carbohydrate breakfast test meals on three occasions separated by one week: two enriched with thylakoids and one control. Blood samples and visual analogue scale (VAS) questionnaires were tracked over a 4-hour period. Adding thylakoids suppressed hunger motivation, increased CCK secretion starting from 180 minutes, and prevented postprandial hypoglycaemia starting from 90 minutes after food intake.
Stenblom EL, Montelius C, Östbring K, et al. Appetite, 2013. PMID 23632035
2013 / Randomized crossover trial
A randomized crossover trial in 17 obese, insulin-sensitive individuals evaluated metabolic responses during an oral glucose tolerance test preceded by sucralose or water. Sucralose ingestion resulted in a higher peak glucose increase (4.8 ± 0.3 vs. 4.2 ± 0.2 mmol/L, P = 0.03) and a 20 ± 8% larger insulin area under the curve (P < 0.03). Insulin clearance decreased by 7 ± 4% (P = 0.04) and insulin sensitivity decreased by 23 ± 20% (P = 0.01).
Pepino MY, Tiemann CD, Patterson BW, et al. Diabetes Care, 2013. PMID 23633524
2013 / Randomized, double-blind, placebo-controlled trial
A randomized, double-blind, placebo-controlled trial evaluated the effect of adding 20 mg elemental zinc/day versus placebo to antibiotics and supportive care in 550 hospitalized children aged 2-24 months with severe or very severe pneumonia. The time to recovery was similar between groups (HR: 0.98; 95% CI: 0.82, 1.17). In stratified analysis, zinc reduced recovery time in children with very severe pneumonia (HR: 1.52; 95% CI: 1.03, 2.23), but this effect was no longer statistically significant after adjusting for differences in severely underweight children between groups.
Wadhwa N, Chandran A, Aneja S, et al. Am J Clin Nutr, 2013. PMID 23636236
2013 / Randomized crossover trial
A randomized crossover trial evaluated 10 healthy men receiving 70, 140, or 280 ml of beetroot juice or nitrate-depleted placebo. Ingesting 140 and 280 ml reduced steady-state oxygen uptake during moderate exercise by 1.7% (P = 0.06) and 3.0% (P < 0.05), respectively, and increased time-to-task failure by 14% and 12% (both P < 0.05). Plasma nitrite concentrations rose dose dependently, but performance did not differ between the two higher doses.
Wylie LJ, Kelly J, Bailey SJ, et al. J Appl Physiol (1985), 2013. PMID 23640589
2013 / Uncontrolled clinical trial
Seven patients seeking non-pharmacological treatment for PCOS consumed a beverage containing 15 g of apple vinegar daily for 90 to 110 days. Intake of the vinegar beverage resulted in a decrease of the HOMA-R index in six patients, alongside a decrease in the LH/FSH ratio in five of seven patients. Ovulatory menstruation was observed within 40 days in four of seven patients.
Wu D, Kimura F, Takashima A, et al. Tohoku J Exp Med, 2013. PMID 23666047
2013 / Crossover trial
Six healthy participants consumed 400 mL of commercial orange juice (containing 100 mg vitamin C and 40.8 g sugar) and, one week later, consumed a control drink of 400 mL water with 100 mg vitamin C and 40.8 g glucose. Blood was collected before and 2 hours after ingestion to assess lymphocyte DNA damage via comet assay. Supplementation with orange juice resulted in a significant decrease in hydrogen peroxide-induced DNA damage at 2 hours, with no change in baseline DNA damage. The control trial showed no significant decrease in lymphocyte DNA damage.
Szeto YT, To TL, Pak SC, et al. Appl Physiol Nutr Metab, 2013. PMID 23668761
2013 / Phase I dose-escalation clinical trial
Five cohorts of three patients with advanced solid tumors received intravenous ascorbic acid at 1 g/min for 4 consecutive days per week for 4 weeks, starting at 30 g/m² with 20 g/m² dose escalations. Ascorbic acid was eliminated by first-order kinetics with a half-life of 2.0 ± 0.6 h and clearance of 21 ± 5 dL/h m². Cmax and AUC increased with dose up to 70 g/m² (reaching 49 mM and 220 h mM, respectively). All doses were well tolerated, but no patient demonstrated an objective antitumor response.
Stephenson CM, Levin RD, Spector T, et al. Cancer Chemother Pharmacol, 2013. PMID 23670640
2013 / Single-blind placebo-controlled crossover trial
In a 3-month trial, 15 postmenopausal women took 5 g daily of placebo for 4 weeks, seaweed (Undaria) for 4 weeks, and placebo for another 4 weeks. Urinary creatinine-standardized uPAR decreased significantly during seaweed intake (placebo 1: 1.5 [95% CI, 0.9-2.1]; seaweed: 0.9 [95% CI, 0.6-1.1]; placebo 2: 1.7 [95% CI, 1.2-2.2]; p = 0.01). A urinary protein (m/z 9,776) showed a similar reversible decrease, while a serum protein (m/z 8,928) reversibly increased.
Teas J, Vena S, Cone DL, et al. J Appl Phycol, 2013. PMID 23678231
2013 / Randomized crossover pilot trial
In a pilot study, subjects consumed raw salad vegetables and 8 g canola oil over two meals in three randomized meal patterns: 100% in meal one and 0% in meal two, 75% in meal one and 25% in meal two, or 50% in each meal. Total carotenoid absorption (AUC) was greatest when ≥75% of vegetables were consumed in a single meal (P < .05). Carotene absorption (α- and β-carotene) followed this trend (P < .05), and xanthophyll absorption was higher when consuming 100% of vegetables in one meal compared to 50% at each meal (P < .05).
NANO counterpoint →
Goltz SR, Sapper TN, Failla ML, et al. Nutr Res, 2013. PMID 23684437
2013 / Randomized crossover trial
In a randomized crossover trial of 25 overweight or obese adults with pre-diabetes, participants ingested 0, 13, or 26 g of ground flaxseed daily for 12 weeks. Fasting glucose, insulin, and HOMA-IR significantly dropped during the 13 g intervention relative to control, whereas the 26 g dose showed no significant reductions. Levels of fructosamine, adiponectin, C-reactive protein, and interleukin-6 were unaltered across all phases.
Hutchins AM, Brown BD, Cunnane SC, et al. Nutr Res, 2013. PMID 23684438
2013 / Randomized controlled trial
In a randomized controlled trial of elderly adults with mild cognitive impairment over two years, daily high-dose B vitamins (0.8 mg folic acid, 20 mg B6, 0.5 mg B12) slowed whole-brain shrinkage and reduced gray matter atrophy in Alzheimer-vulnerable regions up to sevenfold. This protective effect was restricted to participants with baseline homocysteine levels above 11 micromol/L. In that subgroup, B-vitamin therapy countered the rapid gray matter loss linked to elevated homocysteine.
Douaud G, Refsum H, de Jager CA, et al. Proc Natl Acad Sci U S A, 2013. PMID 23690582
2013 / Multicenter randomized controlled trial
Over 18 weeks, corporate employees randomized to a low-fat vegan diet experienced greater reductions in body weight (-2.9 kg vs -0.06 kg, P < 0.001) and glycated hemoglobin (-0.6 vs -0.08 percentage points, P < 0.01) than controls. Total cholesterol dropped 8.0 mg/dl versus 0.01 mg/dl, and LDL cholesterol decreased 8.1 mg/dl versus 0.9 mg/dl (P < 0.01).
Mishra S, Xu J, Agarwal U, et al. Eur J Clin Nutr, 2013. PMID 23695207
2013 / Randomized controlled trial
In the Women's Health Initiative Dietary Modification trial, 48,835 postmenopausal women were randomized to a low-fat dietary pattern intervention (n = 19,541) or a comparison group (n = 29,294) with a target of decreasing fat to 20% or less of calories and increasing vegetables, fruits, and grains. Over 8.1 years of follow-up, the intervention did not significantly affect overall incidence of NMSC (HR 0.98; 95% CI, 0.92-1.04) or melanoma (HR 1.04; 95% CI, 0.82-1.32). However, a significant interaction was observed between baseline fat intake and group assignment for melanoma risk (Pinteraction = 0.006), showing increased risk with the intervention among women with higher baseline fat intake (HR 1.48; 95% CI, 1.06-2.07) and a trend toward reduced risk among those with lower baseline fat intake (HR 0.72; 95% CI, 0.50-1.02).
Gamba CS, Stefanick ML, Shikany JM, et al. Cancer Epidemiol Biomarkers Prev, 2013. PMID 23697610
2013 / Secondary analysis of 4 complete diet intervention studies
Researchers developed an algorithm to predict nonheme iron absorption using data from 4 complete diet studies involving 53 individuals (159 total observations across three 1-week periods with diets typical, high, or low in meat, tea, calcium, or vitamin C). Multiple linear regression showed that serum ferritin was the most important factor in explaining differences in nonheme iron absorption, while dietary factors had small effects. When validated against single-meal and complete-diet data, algorithm R(2) values were 0.57 (P < 0.001) and 0.84 (P < 0.0001), respectively. Results also suggested that between-person variations explain a large proportion of differences in absorption.
Armah SM, Carriquiry A, Sullivan D, et al. J Nutr, 2013. PMID 23700342